Picture of ReNeuron logo

RENE ReNeuron News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

REG - ReNeuron Group plc - Creditor’s decision on Administrators' Proposals

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240605:nRSE2808Ra&default-theme=true

RNS Number : 2808R  ReNeuron Group plc  05 June 2024

5 June 2024

 

ReNeuron Group plc

("ReNeuron" or the "Company")

 

Notice of Creditor's decision on Joint Administrators' Proposals

 

Further to the announcement of the publication of the Joint Administrators'
Proposals on 17 May 2024, ReNeuron Group plc (in administration) (AIM: RENE),
a UK based leader in stem cell derived exosome technologies, announces that
Mark Smith and Stephen Cork of Cork Gully LLP, the Joint Administrators of the
Company and of its subsidiaries, ReNeuron Limited, ReNeuron (UK) Limited
ReNeuron Holdings Limited (All in Administration) (together the "Group") have
filed the "AM07 - Notice of creditor's decision on administrator's proposals"
at Companies House. The notice will be published by Companies House in due
course.

 

The notice documents that, at 23:59 hours on 30 May 2024, all decisions were
duly approved by creditors.

 

Further updates on the administration process will be made when appropriate

Enquiries:

 

 Cork Gully LLP                     +44 (0)20 7268 2150 or
 Stephen Cork, Joint Administrator  reneuron@corkgully.com
 Mark Smith, Joint Administrator

 ReNeuron                           www.reneuron.com/investors (http://www.reneuron.com/investors)
 Iain Ross, Executive Chairman      Via Walbrook PR

 Allenby Capital Limited (Nominated Adviser and Broker)                                +44 (0)20 3328 5656
 James Reeve/George Payne/Dan Dearden-Williams (Corporate Finance)
 Stefano Aquilino/Kelly Gardiner (Sales & Corporate Broking)

 Walbrook PR (Media & Investor Relations)                    +44 (0)20 7933 8780 or reneuron@walbrookpr.com
                                                             (mailto:reneuron@walbrookpr.com)
 Paul McManus / Alice Woodings      +44 (0)7980 541 893 / +44 (0)7407 804 654

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCBSGDLUXGDGSU

Recent news on ReNeuron

See all news